Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharmaco Consult ApS
APS
Active
CVR 43368451
Skovgårdsvej 65
Business and other management consultancy activities · NACE 7020
Est. 2022
2 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,8M
+74% vs 2024
EBITDA margin
76.9%
+238% vs 2024
Equity ratio
64.4%
Financial strength
Net profit 2025
DKK 1,1M
+214% vs 2024
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2023
0M
-100%
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
DKK 1,8M
+74%
EBITDA
DKK 1,4M
+238%
Net profit
DKK 1,1M
+214%
Total assets
DKK 3M
+80%
Equity
DKK 1,9M
+129%
Employees
2
—
Company information
Legal name
Pharmaco Consult ApS
CVR number
43368451
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
1. juli 2022
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at yde global strategisk rådgivning til Health Care virksomheder.
Contact
Address
Skovgårdsvej 65
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Gentofte
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
2M
2023
1M
2024
2M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
1M
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
1.955
1.031
1.798
Staff expenses
-734
-622
-415
EBITDA
1.221
409
1.383
Depreciation & amort.
-0
-0
-0
EBIT
1.221
409
1.383
Net financials
9
37
-2
Profit before tax
1.229
445
1.381
Tax
279
103
309
Net profit
950
342
1.073
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
1.583
1.641
2.958
Equity
990
832
1.905
Long-term debt
0
0
0
Short-term debt
593
808
1.053
Total debt
593
808
1.053
Financial ratios
5-year trend
EBITDA margin
76.9%
This company
15.8%
Market median
+387% vs market
2023
2025
Equity ratio
64.4%
This company
38.2%
Market median
+69% vs market
2023
2025
Return on equity
56.3%
This company
18.4%
Market median
+206% vs market
2023
2025
Net profit margin
59.7%
This company
8.1%
Market median
+637% vs market
2023
2025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
2023
2025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-07-01 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
JH
Jesper Høiland
Management
Management
2022
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
JesH Holding ApS
Company
100.0%
100.0%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
JesH Holding ApS
Pharmaco Consult ApS
(this company)
Board network connections
Board members of Pharmaco Consult ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Jesper Høiland
Management
0 companies